Company: ATMCW
Filing Date: 2025-11-17
Form Type: DEFM14A
Source: 0001493152-25-023842
Chunk: 76

Company: ALPHATIME ACQUISITION CORP
Filing Date: 2025-11-17
Form: DEFM14A
Chunk 76
---
 be applicable to us and/or our subsidiary, we cannot assure you that we and our subsidiary will be compliant with such new regulations in all respects, and we and/or our subsidiaries may be ordered to rectify and terminate any actions that are deemed illegal by the PRC governmental authorities and become subject to fines and other government sanctions, which may materially and adversely affect our subsidiaries’ business and our financial condition and results of operations.

CSRC Filing

On February 17, 2023, the CSRC promulgated Trial Administrative Measures of the Overseas Securities Offering and Listing by Domestic Companies (the “ Overseas Listing Trial Measures”) and circulated five supporting guidelines, which became effective on March 31, 2023. The Overseas Listing Trial Measures regulate both direct and indirect overseas offering and listing of PRC domestic companies’ securities by adopting a filing-based regulatory regime.

In light of China’s
extension of its authority into Hong Kong, HCYC may be subject to risks arising from the legal system in Hong Kong and China
associated with HCYC HK’s operations. After HCYC management’s review of PRC laws and regulations regarding the filing
requirements, as of the date of this prospectus, HCYC does not believe that they are required to obtain the approval from or
complete the filing with the CSRC pursuant to the Trial Administrative Measures for this offering. Additionally, HCYC has been
advised by Yingke Law Firm, our PRC counsel, that based on their understanding of the current PRC laws and regulations, as of the date of this
prospectus, HCYC and its operating subsidiary HCYC HK, are not required to obtain any permissions or approvals from Hong Kong
authorities for the continued listing of our ordinary shares in the U.S. and issuing our ordinary shares to foreign investors. Thus,
HCYC has not submitted an application for approval for this offering with the CSRC. HCYC has obtained a legal opinion fromYingke Law
Firm regarding this matter, based on the facts that (i) its principal business activities, via HCYC HK, are conducted in Hong Kong,
not Mainland China (ii) its principal place of business is in Hong Kong, not Mainland China; and, (iii) all of its directors and
officers are citizens of Hong Kong and reside in Hong Kong. As of the date of this prospectus, HCYC HK received all requisite
permissions or approvals from the Hong Kong authorities to operate their